"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest releases series of White Papers in 2016

Pharmatest Services Ltd releases three White Papers during 2016. The first White Paper was released before the AACR Annual Meeting on April. The second White Paper will be released before the Hanson Wade Tumor Models event on July and the third before the ASBMR Annual Meeting on September.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases.

Pharmatest released the first White Paper “Orthotopic and Metastasis Models for Preclinical Efficacy Testing of Novel Cancer Drugs” on April 2016. The White Paper was distributed in the AACR Annual Meeting held in New Orleans on April 16 - 20. Please download your copy of our White Paper here.

The second White Paper will describe in more detail metastasis models of Pharmatest. It will be released before the Hanson Wade Tumor Models event held in Boston, MA, on July 19 – 21 and distributed in the event. Pharmatest has a sponsored talk in the event titled “Why and How to Test Drug Efficacy in Mouse Models of Bone Metastasis.”

The third White Paper describing skeletal disease models of Pharmatest will be released before the ASBMR Annual Meeting held in Atlanta, GA, on September 16 – 19 and distributed in the event. Pharmatest will have a booth and several poster presentations in the event.

More detailed news related to the events mentioned above will be published later before the events. To schedule a meeting with our representatives during the events click here for e-mail.